| 000 | 01673 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250516184134.0 | ||
| 264 | 0 | _c20150120 | |
| 008 | 201501s 0 0 eng d | ||
| 022 | _a1930-739X | ||
| 024 | 7 |
_a10.1002/oby.20653 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aVan Pelt, R E | |
| 245 | 0 | 0 |
_aEstrogen or raloxifene during postmenopausal weight loss: adiposity and cardiometabolic outcomes. _h[electronic resource] |
| 260 |
_bObesity (Silver Spring, Md.) _cApr 2014 |
||
| 300 |
_a1024-31 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural | ||
| 650 | 0 | 4 |
_aAdiposity _xdrug effects |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aBlood Glucose _xmetabolism |
| 650 | 0 | 4 |
_aBody Composition _xdrug effects |
| 650 | 0 | 4 | _aEnergy Metabolism |
| 650 | 0 | 4 | _aEstrogen Replacement Therapy |
| 650 | 0 | 4 |
_aEstrogens _xpharmacology |
| 650 | 0 | 4 | _aExercise |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInsulin _xblood |
| 650 | 0 | 4 |
_aLipids _xblood |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aObesity _xmetabolism |
| 650 | 0 | 4 |
_aPostmenopause _xblood |
| 650 | 0 | 4 |
_aRaloxifene Hydrochloride _xpharmacology |
| 650 | 0 | 4 |
_aSelective Estrogen Receptor Modulators _xpharmacology |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aWeight Loss _xdrug effects |
| 700 | 1 | _aGozansky, W S | |
| 700 | 1 | _aWolfe, P | |
| 700 | 1 | _aKittelson, J M | |
| 700 | 1 | _aJankowski, C M | |
| 700 | 1 | _aSchwartz, R S | |
| 700 | 1 | _aKohrt, W M | |
| 773 | 0 |
_tObesity (Silver Spring, Md.) _gvol. 22 _gno. 4 _gp. 1024-31 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/oby.20653 _zAvailable from publisher's website |
| 999 |
_c23341764 _d23341764 |
||